SCHEMBL7923582

SCHEMBL7923582

CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCCCCC)CN1CCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGCG Q16739 8/20 0.55
PLA2G2C Q5R387 1/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
FAAH O00519 2/20 0.53
MAPK1 P28482 2/20 0.53
DNM1 Q05193 1/20 0.51
PLA2G10 O15496 2/20 0.50
HTR1A P08908 1/20 0.47
PTGS1 P23219 1/20 0.47
OPRM1 P35372 1/20 0.47
ALDH1A1 P00352 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NOD1 Q9Y239 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
NFKB1 P19838 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13493025 1.00 UGCG (0.55) UGCGPLA2G2CMEN1KMT2AFAAH
SCHEMBL5316566 0.89 UGCG (0.55) UGCGPLA2G2CMEN1KMT2AFAAH
SCHEMBL19287146 0.89 UGCG (0.55) UGCGPLA2G2CMEN1KMT2AFAAH
SCHEMBL20382547 0.83 UGCG (0.43) UGCGPLA2G2CMEN1KMT2AFAAH
SCHEMBL19043452 0.82 MEN1 (0.60) UGCGMEN1KMT2AFAAHMAPK1
SCHEMBL12406955 0.82 MEN1 (0.64) UGCGMEN1KMT2AFAAHMAPK1
SCHEMBL17636001 0.82 MEN1 (0.64) UGCGMEN1KMT2AFAAHMAPK1
SCHEMBL12406957 0.82 MEN1 (0.64) UGCGMEN1KMT2AFAAHMAPK1
SCHEMBL25067268 0.81 PLA2G2C (0.77) PLA2G2CMEN1KMT2AFAAHMAPK1
SCHEMBL31364557 0.81 PLA2G2C (0.77) PLA2G2CMEN1KMT2AFAAHMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2594563-B1 2-acylaminopropanol-type glucosylceramide synthase inhibitors GENZYME CORP (US) 2018-07-18 EP disclosed
US-9745294-B2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors GENZYME CORPORATION (US) 2017-08-29 US disclosed
WO-2010039256-A1 2-ACYLAMINOPROPOANOL-TYPE GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GENZYME CORPORATION (US) 2010-04-08 WO disclosed
WO-2010014554-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITION FOR THE TREATMENT OF COLLAPSING GLOMERULOPATHY AND OTHER GLOMERULAR DISEASE GENZYME CORPORATION (US) 2010-02-04 WO disclosed
WO-2008150486-A2 2-ACYLAMINOPROPOANOL-TYPE GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GENZYME CORPORATION (US) 2008-12-11 WO disclosed